Oxford Nanopore Technologies (LON:ONT – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Thursday,London Stock Exchange reports. They currently have a GBX 195 target price on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 29.46% from the stock’s previous close.
A number of other analysts have also commented on ONT. Berenberg Bank decreased their price objective on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating for the company in a report on Wednesday. Citigroup lowered Oxford Nanopore Technologies to a “buy” rating in a report on Monday, July 20th. Peel Hunt restated a “hold” rating and set a GBX 153 price objective on shares of Oxford Nanopore Technologies in a research note on Monday, July 13th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Oxford Nanopore Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 193.25.
Check Out Our Latest Stock Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last posted its earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Featured Articles
- Five stocks we like better than Oxford Nanopore Technologies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
